NEW YORK, Sept. 9 /PRNewswire/ -- Future Pharmaceuticals features an exclusive interview with Dave Champagne, Vice President and General Manager of Informatics at Thermo Fisher Scientific, and Thor-Gunnar Steinsli, LIMS Manager and Chief Engineer at HUNT Research Center and Biobank, about data integration: the benefits of data, instrument and enterprise integration strategies and challenges at life sciences companies.
"One of the biggest challenges facing life sciences companies has to do with managing the ever-growing volume of data and connecting all of the disparate sources of data throughout an organization," Champagne said.
"HUNT Biobank is a vivid example of the benefits of this type of integrated solution who helped us secure Microsoft's prestigious Pharmaceutical and Life Sciences Innovation Award in Discovery and Product Innovation (for more information visit http://www.thermo.com/informatics)," Champagne added.
The Director of Global Quality Labs at Eli Lilly, Jackie Larew, is featured in this issue leading an expert panel around issues facing the supply chain. One of the questions she poses to the panel is around the recent concerns we've seen with pet food and milk products tainted with melamine and contaminated heparin entering the U.S. supply chain. "What implications does this have for the way pharmaceutical companies ensure quality from their suppliers with an increasingly global supply chain of raw materials?" Larew asked the panelists.
This edition of FP also delves into the changing world of cell-based therapy. Mark Thiede, Research Fellow with Pfizer for the Genetically Modified Models Center of Emphasis, guest moderates a panel discussion on the future of the cellular therapy industry. Read the piece, Diagnosis: Cell-based Therapy
|SOURCE Future Pharmaceuticals|
Copyright©2009 PR Newswire.
All rights reserved